PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Saldarriaga Vargas, C.* ; Andersson, M.* ; Bouvier-Capely, C.* ; Li, W.B. ; Madas, B.* ; Covens, P.* ; Struelens, L.* ; Strigari, L.*

Heterogeneity of absorbed dose distribution in kidney tissues and dose-response modelling of nephrotoxicity in radiopharmaceutical therapy with beta-particle emitters: A review.

Z. Med. Phys. 34, 491-509 (2023)
Postprint DOI PMC
Open Access Gold
Absorbed dose heterogeneity in kidney tissues is an important issue in radiopharmaceutical therapy. The effect of absorbed dose heterogeneity in nephrotoxicity is, however, not fully understood yet, which hampers the implementation of treatment optimization by obscuring the interpretation of clinical response data and the selection of optimal treatment options. Although some dosimetry methods have been developed for kidney dosimetry to the level of microscopic renal substructures, the clinical assessment of the microscopic distribution of radiopharmaceuticals in kidney tissues currently remains a challenge. This restricts the anatomical resolution of clinical dosimetry, which hinders a thorough clinical investigation of the impact of absorbed dose heterogeneity. The potential of absorbed dose-response modelling to support individual treatment optimization in radiopharmaceutical therapy is recognized and gaining attraction. However, biophysical modelling is currently underexplored for the kidney, where particular modelling challenges arise from the convolution of a complex functional organization of renal tissues with the function-mediated dose distribution of radiopharmaceuticals. This article reviews and discusses the heterogeneity of absorbed dose distribution in kidney tissues and the absorbed dose-response modelling of nephrotoxicity in radiopharmaceutical therapy. The review focuses mainly on the peptide receptor radionuclide therapy with beta-particle emitting somatostatin analogues, for which the scientific literature reflects over two decades of clinical experience. Additionally, detailed research perspectives are proposed to address various identified challenges to progress in this field.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Altmetric
2.000
0.000
2
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Schlagwörter Absorbed Dose Heterogeneity ; Biophysical Modelling ; Dose–response Modelling ; Kidney Dosimetry ; Normal Tissue Complication Probability (ntcp) ; Radiopharmaceutical Therapy; Receptor Radionuclide Therapy; Radiation-induced Complications; Individualized Dosimetry; Neuroendocrine Tumors; Digital Autoradiography; Parallel Architecture; Renal Retention; S Values; Volume; Probability
Sprache englisch
Veröffentlichungsjahr 2023
HGF-Berichtsjahr 2023
ISSN (print) / ISBN 0939-3889
e-ISSN 1876-4436
Zeitschrift Zeitschrift für Medizinische Physik
Quellenangaben Band: 34, Heft: 4, Seiten: 491-509 Artikelnummer: , Supplement: ,
Verlag Elsevier
Verlagsort Radarweg 29, 1043 Nx Amsterdam, Netherlands
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Radiation Medicine (IRM)
POF Topic(s) 30203 - Molecular Targets and Therapies
Forschungsfeld(er) Radiation Sciences
PSP-Element(e) G-501391-001
DOI 10.1016/j.zemedi.2023.02.006
WOS ID 001360543200001
Scopus ID 85151882430
PubMed ID 37031068
Erfassungsdatum 2023-10-06
[➜Korrektur melden]